Outsourced Pharma Capacity Update – Large Molecule, March 2026

Home | Outsourced Pharma Capacity Update – Large Molecule, March 2026

Mark Santos, VP Commercial Development, Biologics, shares how our expertise in microbial strain & process development enables our partners to swiftly progress to GMP. This video comes from the March 2026 Outsourced Pharma Capacity Update event.

Primary Interest(Required)
Segments(Required)
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy